CNSide Diagnostics logo
Order a Test

Plus Therapeutics and CNSide Diagnostics Highlight LM Advances at SNO/ASCO 2025

by | Aug 19, 2025 | News

Collaboration Spotlight: Advancing Leptomeningeal Metastases Research

Last week, the leadership teams from Plus Therapeutics and CNSide Diagnostics came together onsite at #SNOASCO2025 in Baltimore, Maryland.

Their jointly sponsored symposium on leptomeningeal metastases (LM) was the most attended ISS symposium of the event, highlighting growing interest in cutting-edge approaches to CNS metastases detection and management.

Key Achievements at the Conference

  • FORESEE Poster Award: The CNSide and Dr. Priya Kumthekar poster on longitudinal detection and monitoring of LM received first place, underscoring its clinical impact.
  • Engagement with KOLs & Advocacy Groups: Leadership teams held multiple meetings with key opinion leaders and patient advocacy groups, fostering collaborations for research and clinical care.
  • Symposium Recording Available: For those who missed it, you can request a recording of the symposium here.

About CNSide Diagnostics

CNSide Diagnostics is dedicated to transforming CNS cancer care through its CSF assay platform, enabling sensitive detection, longitudinal monitoring, and personalized treatment strategies for patients with leptomeningeal metastases.

#PlusTherapeutics #CNSide #SNOASCO2025 #LeptomeningealMetastases #LM #CNSCancer #NeuroOncology #CancerDiagnostics #PrecisionMedicine #BrainCancer

Written By CNSide Diagnostics

undefined
More Posts by CNSide

Related Posts

Two New Strategic Executive Hires

Dec 9, 2025 |

Expanding operational and regulatory expertise to support commercialization and growth Plus Therapeutics (NASDAQ: PSTV) today announced two key leadership additions to CNSide Diagnostics, its wholly-owned subsidiary, further strengthening the company’s operational...

read more

Houston Business Journal

Dec 5, 2025 |

Strengthening CNS oncology diagnostics at the heart of America’s largest medical ecosystem CNSide Diagnostics, a subsidiary of Plus Therapeutics (NASDAQ: PSTV), has officially expanded into Levit Green, a premier life sciences innovation campus developed by Hines in...

read more

0 Comments